Global Presence Ceva Santé Animale operates in 47 countries with a workforce of over 7,000 employees, demonstrating extensive international reach and market penetration. This global footprint presents opportunities for customized regional solutions and cross-border product expansion.

Innovative R&D Focus With 21 research and development centers and a strong commitment to innovation, Ceva is continually developing advanced animal health products. Collaborating on R&D initiatives or offering complementary technological solutions could enhance their product pipeline.

Strategic Partnerships Recent collaborations with Microchip, Elliptic Labs, and MabGenesis highlight Ceva’s openness to integrating cutting-edge technologies such as semiconductors, AI sensors, and monoclonal antibody discovery. Opportunities exist to propose innovative tech integrations or joint ventures.

Sustainability & CSR Ceva actively engages in community and animal welfare campaigns, such as partnerships with Battersea Dogs Home. Offering sustainability-focused solutions or CSR collaboration options may align with their corporate values and expand brand goodwill.

Market Leadership As the fifth largest global animal health company with a 2024 revenue of €1.77 billion, Ceva holds a strong market position. Targeted sales pitches emphasizing product innovation, regulatory support, and global distribution capabilities can resonate well with their strategic priorities.